From: A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
 | # of markers | Model | AUC/Train (25/58)a | AUC/Test (13/29)a | AUC/ALL (87)b |
DRE | 2 | HOXA7, HOXB5 | 0.897 | 0.898 | 0.892 |
3 | HOXA7, HOXB5, HOXD3b | 0.911 | 0.869 | 0.898 | |
4 | HOXA7, HOXB5, HOXD3b, AOX1rc | 0.915 | 0.875 | 0.91 | |
5 | ADCY4, HOXA7, HOXB5, NODAL, MOXD1 | 0.89 | 0.909 | 0.9 | |
5 | HOXA7, HOXD10, APC, GFRA2, KIFC2 | 0.892 | 0.886 | 0.888 | |
6 | HOXA7, HOXB5, HOXD3b, HOXD9, GFRA2, AOX1rc | 0.907 | 0.875 | 0.897 | |
7 | HOXA7, HOXB5, HOXD3b, HOXD10, KIFC2, AOX1rc, HOXD3a | 0.912 | 0.875 | 0.903 | |
8 | ADCY4, HOXA7, HOXD3b, HOXB5, HOXD9, HOXD10, NODAL, KIFC2rc | 0.891 | 0.847 | 0.876 | |
11 | ADCY4, HOXA7, HOXB5, HOXD9, GSTP1, RASSF5, EPHX3, HEMK1rc, KIFC2, MOXD1, AOX1rc | 0.916 | 0.949 | 0.925 | |
 | # of markers | Model | AUC/Train (20/45)a | AUC/Test (12/22)a | AUC/ALL (67)b |
FV | 2 | HOXD3b, RASSF5 | 0.902 | 0.936 | 0.915 |
3 | HOXB5, HOXD3b, RASSF5 | 0.866 | 0.891 | 0.873 | |
3 | HOXD3b, MOXD1, RASSF5 | 0.915 | 0.936 | 0.926 | |
4 | ADCY4, HOXD3b, RASSF5, KIFC2 | 0.858 | 0.827 | 0.854 | |
6 | HOXB5, HOXD3b, MOXD1, RASSF5, CXCL14, KIFC2 | 0.894 | 0.845 | 0.88 | |
8 | ADCY4, HOXD3b, HOXD10, HOXD3a, MOXD1, RASSF5, CXCL14, GSTP1 | 0.902 | 0.882 | 0.895 | |
8 | ADCY4, HOXB5, HOXD3b, HOXA7, HOXD9, HOXD3a, RASSF5, AOX1rc | 0.824 | 0.891 | 0.846 | |
8 | ADCY4, HOXA7, HOXD3b, HOXB5, HOXD9, HOXD10, NODAL, KIFC2rc | 0.822 | 0.882 | 0.833 |